A case control etiologic study of sarcoidosis: environmental and occupational risk factors.
about
Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis protocol"Sarcoid like" granulomatous pulmonary disease in World Trade Center disaster respondersEtiology of sarcoidosis: does infection play a role?Hepatic SarcoidosisOccupational pesticide exposures and respiratory health.Granuloma formation in pulmonary sarcoidosisSarcoidosis: Immunopathogenesis and Immunological MarkersAssessment of cardiac sarcoidosis with advanced imaging modalitiesLöfgren's syndrome: human leukocyte antigen strongly influences the disease courseA review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxinsCarbon Nanotubes and Chronic Granulomatous DiseaseAssociation Between Occupational Exposures and Sarcoidosis: An Analysis From Death Certificates in the United States, 1988-1999Fungal cell wall agents and bacterial lipopolysaccharide in organic dust as possible risk factors for pulmonary sarcoidosisThe role of PPARγ in carbon nanotube-elicited granulomatous lung inflammationCardiac sarcoidosis: a comprehensive reviewPotential etiologic agents in sarcoidosis.Sarcoidosis in an Italian province. Prevalence and environmental risk factors.Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis.Overexpression of IL-17RC associated with ocular sarcoidosis.Proteomic changes of alveolar lining fluid in illnesses associated with exposure to inhaled non-infectious microbial particles.Efficient generalized least squares method for mixed population and family-based samples in genome-wide association studies.Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory SarcoidosisFungal exposure and low levels of IL-10 in patients with sarcoidosis.Prevalence and clinical picture of musculoskeletal sarcoidosis.Sarcoidosis--scientific progress and clinical challenges.Neurosarcoidosis: guidance for the general neurologist.Sarcoidosis - a clinically orientated review.Extrapulmonary manifestations of sarcoidosis.Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibilityFungal exposure in homes of patients with sarcoidosis - an environmental exposure study.M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosisSarcoidosis treatment with antifungal medication: a follow-up.Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancersSmoking inhibits the frequency of bronchovascular bundle thickening in sarcoidosisInflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosisMolecular analysis of sarcoidosis lymph nodes for microorganisms: a case-control study with clinical correlates.Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.
P2860
Q23911842-ACB9722D-4E3F-4C5C-8314-756C3B63A7EAQ23916693-1963FC2A-1163-4A9B-851E-20C715277908Q24608971-8992273C-FB61-491B-9F91-02BB6AB0FA50Q26822834-58ECFBE2-BE0E-466A-ACEC-F2E700F4FE92Q26822949-389D5D59-D76A-42D6-8A04-22159D5007B9Q26863703-C6496AA5-5E19-466B-8B4B-4FD9D3DB9597Q27006756-01C9AB7A-33CA-42EC-B63B-8C946D77BE96Q27024252-24EE39AD-687C-4FED-A562-64DC2FB698B6Q28300383-A65C3A32-4648-4746-9D81-D638D0C9CB33Q28382991-B5A10BE5-8262-451B-B998-3338A347241BQ28384246-959315D5-7A9C-42EF-8485-7E84710B947DQ28386288-9FD8ADA8-0358-4426-95D3-506CFC0FAECFQ28389809-2D3CB724-686B-444F-B709-63F53C99BDB4Q28393864-3FE9F2C9-A4D4-494E-899A-6F48A61B23BCQ30471147-78F11D86-38EB-4D87-B58A-F0F52634503AQ33293512-6FAE3BBD-17BC-4F51-83AF-023E60172C0BQ33642974-FA077862-C4BC-462F-B6C7-F7200E1E93BEQ33723775-89E1627C-2EB2-4CF5-B5E6-D8A73BFCE9A7Q33732137-10F4DC80-F193-424D-9132-6D42C6E139B6Q33762598-25AAADF1-88C5-4B60-90F0-94830A4BCCE7Q33916460-4F51D60D-2422-401C-A613-7401ED78A027Q33956296-8764F1FF-24F7-4E8C-9E70-F196A5336D22Q33997625-587C8E0C-22FE-4BBF-B7B4-FD73D15DDA8CQ34050113-DBF42032-3451-4FFB-9032-5410C45B8E2AQ34080173-973BC57B-7485-4D65-A321-F94C93D95545Q34197381-322668CD-91F9-44A3-AF1E-77E78AD54FC5Q34199947-5F5B7150-EFAE-43E0-A627-97F9DA45A645Q34236242-7C9B7871-B886-4E73-AA6B-8943FA22D5C5Q34291268-9DEDC7CB-64E4-4E4A-AA50-F4D4F75C5233Q34340121-BADC3DD7-4D76-481E-A302-00E97D0D0D4FQ34405821-E4C8A0AA-3B63-4384-8F09-2028590F0E2EQ34564261-77CD2677-829C-4814-BE84-2F6305B95A4CQ34756244-CC9FEFA2-8900-4612-951E-2862BF4E93DFQ34762582-B6082148-C9A2-4C1B-9C6B-231B710C1425Q34935542-577474B9-C480-43B5-AFFC-3B7DB7CA5E4DQ35046451-B13004E4-A0D9-4516-9E15-65A6D3BD27E7Q35066461-8F55357D-D6B0-4C90-88D4-794245155AD2Q35075020-0E0D4CB6-F19E-4AB9-A08B-D7621C258252Q35152804-7CD9108A-A316-49CB-9075-70F8BD4E0660Q35497307-100D32C4-F93A-4669-B440-475197AECA90
P2860
A case control etiologic study of sarcoidosis: environmental and occupational risk factors.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A case control etiologic study ...... and occupational risk factors.
@ast
A case control etiologic study ...... and occupational risk factors.
@en
type
label
A case control etiologic study ...... and occupational risk factors.
@ast
A case control etiologic study ...... and occupational risk factors.
@en
prefLabel
A case control etiologic study ...... and occupational risk factors.
@ast
A case control etiologic study ...... and occupational risk factors.
@en
P2093
P2860
P1476
A case control etiologic study ...... and occupational risk factors.
@en
P2093
ACCESS Research Group
Alvin S Teirstein
Benjamin A Rybicki
Bruce W Thompson
Carol J Johns
Cecile S Rose
David L Rabin
David R Moller
Eddy A Bresnitz
Gary Hunninghake
P2860
P304
P356
10.1164/RCCM.200402-249OC
P407
P577
2004-09-03T00:00:00Z